Dieudonné Lufwa
Research Subjects
Research Interests
Dieudonné Lufwa has a total of 10 co-authors. Here are the top co-authors by number of shared publications:
- Amadou Bailo Diallo
World Health Organization, Country Office, Lomé BP 1504, Togo
1 shared publication - Aminata Tolno
Bureau de Pays de l'Organisation Mondiale de la Santé pour la Guinée, Immeuble BAH, Quartier Cameroun, BP: 817, Conakry, Guinea
1 shared publication - Boubacar Diallo
World Health Organization (WHO), Conakry, Guinea
1 shared publication - Fatoumata Conté
Ministère de la Santé, Boulevard du commerce - Almamya Kaloum, BP: 585, Conakry, Guinea
1 shared publication - Jacques Katomba
Ministry of Public Health of the Democratic Republic of Congo, Kinshasa, Democratic Republic of the Congo
1 shared publication - Lorenzo Subissi
Health Emergency Preparedness and Response Programme, World Health Organization, Geneva, Switzerland
1 shared publication
Latest Publications
- Open Access
- 24 April 2017
- Published by Springer Nature in BMC Infectious Diseases
- Vol. 17 (1) , 304
Lessons learned by surveillance during the tail-end of the Ebola outbreak in Guinea, June-October 2015: a case series
By the end of the 2013–2016 West African Ebola Virus Disease (EVD) outbreaks, a total of 3814 cases (probable and confirmed) and 2544 deaths were reported in Guinea. Clearly, surveillance activities aiming at stopping human-to-human transmission have been the breakthrough of EVD outbreak management, but their application has been at times easier said than done. This article presents five confirmed or probable EVD cases that arose in Conakry towards the end of the Guinea epidemic, which demonstrate flaws in surveillance and follow-up. For case 1, safe burial requirements were not followed. For cases 1 and 2, negative Polymerase Chain Reaction (PCR) results were interpreted as no infection. For the first case, the sample may have not been taken properly while for the second the disease was possibly at its early stage. Case 3 was stopped at a border health checkpoint and despite her high temperature she was allowed to continue the bus journey. For case 4, an oral swab sample was supposedly taken after death but could not be found for retrospective testing. Despite characteristic symptomatology, case 5 was not identified as a suspect case for as long as 3 weeks. In epidemic contexts, health systems must be able to track all samples of suspect cases and deaths, regardless of their laboratory results. Social mobilization in communities and training in health care facilities must be strengthened at the tail of an outbreak, to avoid the natural slackening of disease surveillance, in particular for long-lasting and deadly epidemics.
- 24 April 2017
- Published by Springer Nature in BMC Infectious Diseases
- Vol. 17 (1) , 304
Open AccessLessons learned by surveillance during the tail-end of the Ebola outbreak in Guinea, June-October 2015: a case series
By the end of the 2013–2016 West African Ebola Virus Disease (EVD) outbreaks, a total of 3814 cases (probable and confirmed) and 2544 deaths were reported in Guinea. Clearly, surveillance activities aiming at stopping human-to-human transmission have been the breakthrough of EVD outbreak management, but their application has been at times easier said than done. This article presents five confirmed or probable EVD cases that arose in Conakry towards the end of the Guinea epidemic, which demonstrate flaws in surveillance and follow-up. For case 1, safe burial requirements were not followed. For cases 1 and 2, negative Polymerase Chain Reaction (PCR) results were interpreted as no infection. For the first case, the sample may have not been taken properly while for the second the disease was possibly at its early stage. Case 3 was stopped at a border health checkpoint and despite her high temperature she was allowed to continue the bus journey. For case 4, an oral swab sample was supposedly taken after death but could not be found for retrospective testing. Despite characteristic symptomatology, case 5 was not identified as a suspect case for as long as 3 weeks. In epidemic contexts, health systems must be able to track all samples of suspect cases and deaths, regardless of their laboratory results. Social mobilization in communities and training in health care facilities must be strengthened at the tail of an outbreak, to avoid the natural slackening of disease surveillance, in particular for long-lasting and deadly epidemics.